Literature DB >> 11604041

Protocols for bridging the peptide to nonpeptide gap in topological similarity searches.

R P Sheridan1, S B Singh, E M Fluder, S K Kearsley.   

Abstract

Similarity searches based on chemical descriptors have proven extremely useful in aiding large-scale drug screening. Typically an investigator starts with a "probe", a drug-like molecule with an interesting biological activity, and searches a database to find similar compounds. In some projects, however, the only known actives are peptides, and the investigator needs to identify drug-like actives. 3D similarity methods are able to help in this endeavor but suffer from the necessity of having to specify the active conformation of the probe, something that is not always possible at the beginning of a project. Also, 3D methods are slow and are complicated by the need to generate low-energy conformations. In contrast, topological methods are relatively rapid and do not depend on conformation. However, unmodified topological similarity methods, given a peptide probe, will preferentially select other peptides from a database. In this paper we show some simple protocols that, if used with a standard topological similarity search method, are sufficient to select nonpeptide actives given a peptide probe. We demonstrate these protocols by using 10 peptide-like probes to select appropriate nonpeptide actives from the MDDR database.

Mesh:

Substances:

Year:  2001        PMID: 11604041     DOI: 10.1021/ci0100144

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  33 in total

1.  A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval.

Authors:  S Joshua Swamidass; Chloé-Agathe Azencott; Kenny Daily; Pierre Baldi
Journal:  Bioinformatics       Date:  2010-04-07       Impact factor: 6.937

2.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

3.  Evaluating docking programs: keeping the playing field level.

Authors:  John W Liebeschuetz
Journal:  J Comput Aided Mol Des       Date:  2008-01-15       Impact factor: 3.686

Review 4.  Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?

Authors:  Johannes Kirchmair; Patrick Markt; Simona Distinto; Gerhard Wolber; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2008-01-15       Impact factor: 3.686

5.  Multiple protein structures and multiple ligands: effects on the apparent goodness of virtual screening results.

Authors:  Robert P Sheridan; Georgia B McGaughey; Wendy D Cornell
Journal:  J Comput Aided Mol Des       Date:  2008-02-14       Impact factor: 3.686

6.  Managing bias in ROC curves.

Authors:  Robert D Clark; Daniel J Webster-Clark
Journal:  J Comput Aided Mol Des       Date:  2008-02-07       Impact factor: 3.686

7.  Bias, reporting, and sharing: computational evaluations of docking methods.

Authors:  Ajay N Jain
Journal:  J Comput Aided Mol Des       Date:  2007-12-13       Impact factor: 3.686

8.  Progress towards automated Kepler scientific workflows for computer-aided drug discovery and molecular simulations.

Authors:  Pek U Ieong; Jesper Sørensen; Prasantha L Vemu; Celia W Wong; Özlem Demir; Nadya P Williams; Jianwu Wang; Daniel Crawl; Robert V Swift; Robert D Malmstrom; Ilkay Altintas; Rommie E Amaro
Journal:  Procedia Comput Sci       Date:  2014

9.  Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.

Authors:  Naga Srinivas Tripuraneni; Mohammed Afzal Azam
Journal:  J Mol Model       Date:  2015-10-26       Impact factor: 1.810

10.  A statistical framework to evaluate virtual screening.

Authors:  Wei Zhao; Kirk E Hevener; Stephen W White; Richard E Lee; James M Boyett
Journal:  BMC Bioinformatics       Date:  2009-07-20       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.